Drug Type Synthetic peptide |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gram-Negative Bacterial Infections | Preclinical | ES | 03 Aug 2024 | |
MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | ES | 03 Aug 2024 |